Findings designate 6i as a prospective candidate exhibiting significant antibacterial, antibiofilm, and host-directed immunomodulatory activities for the treatment of multidrug-resistant bacterial illnesses for the treatment of multidrug-resistant bacterial illnesses.
Abstract
The rise of multidrug-resistant bacteria necessitates the development of novel antimicrobial drugs with enhanced efficiency and safety. This study involved the synthesis and evaluation of a variety of new 1,2,3-triazolyl-sulfonyl-indole derivatives (6a-6o) for their antibacterial, antibiofilm, haemolytic, cytotoxic, immunomodulatory, and molecular docking activities. Among the synthesised compounds, 6h-6j showed significant broad-spectrum antibacterial activity, with compound 6i exhibiting the highest potency (MIC: 1.56-4.16 μg mL-1), comparable to ciprofloxacin and dicloxacillin. Compound 6i exhibited fast bactericidal efficacy, marked suppression of biofilm development, little haemolysis, and reduced macrophage cytotoxicity, signifying superior biocompatibility. It substantially decreased the pro-inflammatory cytokines TNF-α and IL-6, while preserving IL-10 levels. Molecular docking studies on human, mouse, and bovine TLR4 receptors demonstrated advantageous binding interactions, with compound 6i exhibiting the highest and most consistent affinity. These findings designate 6i as a prospective candidate exhibiting significant antibacterial, antibiofilm, and host-directed immunomodulatory activities for the treatment of multidrug-resistant bacterial illnesses.
The presence of fungistatic properties and potential resistance issues associated with current azole drugs have created a growing demand for discovering novel antifungal agents without these negative attributes. This study introduces the synthesis of a unique series of 4-(5-(benzylthio)-1,3,4-oxadiazol-2-yl) phenol der...
Mohammad Shafiei, Sara Masoudinia, Mahfam Moradi et al.· RSC Advances· 0 citations
The global rise of antimicrobial resistance (AMR) has reduced the effectiveness of existing antibiotics, highlighting the urgent need for novel antimicrobial agents. In this study, a series of eighteen naringenin‐based derivatives incorporating 1,3,4‐oxadiazole acylhydrazone moieties were synthesized and evaluated...
Tian-Tian Chen, Qi Hu, Yong Wang et al.· ChemistrySelect· 0 citations
The escalating crisis of multi-drug-resistant pathogens necessitates the development of novel therapeutic scaffolds with enhanced membrane permeability and multi-target inhibitory potential. This study describes the design, synthesis, and mechanistic evaluation of five novel azo-sulfonamide hybrids (4a–e) derived from...
Samar H. Ali, M. El-Zahed, E. Negm et al.· Asia-Pacific Journal of Scie...· 0 citations
The rapid emergence of antimicrobial resistance necessitates the development of novel antimicrobial agents with improved efficacy and favorable safety profiles. In this study, a new series of pyridine-3-carboxamide–1,3,4-thiadiazole hybrids and their corresponding N-Mannich bases bearing structurally diverse piperazine...
Piotr Świątek, Małgorzata Strzelecka, Lukasz Szczukowski et al.· Molecules· 0 citations
A series of new indole-pyrazole-linked isoxazole hybrids (5a-o) were synthesized using Cu(I)-catalyzed 1,3-dipolar cycloaddition and assessed for antibacterial and antibiofilm activities against methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resista...
Venkatesh Reddycherla, K. Chennakesavulu, G. R. Reddy et al.· Asian Journal of Chemistry· 0 citations
The newly developed carvacrol–DABCO amphiphilic hybrids represent a promising class of multitarget antibacterial agents and their broad-spectrum efficacy, bactericidal kinetics, RNA-cleaving activity, low hemolytic toxicity, and favorable selectivity indices support their potential for further in vivo evaluation.
D. Zadvornykh, Mei-Ling Wang, A. Bardasheva et al.· Antibiotics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.